Soligenix, Inc.
USD0.40
+0.00 (+0.68%)
CEO
Christopher J. Schaber
IPO Date
1994-04-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.41
Prev. Close
$0.40
Day Low
$0.40
Day High
$0.41
52W Low
$0.28
52W High
$6.23
Market Cap
$0.00B
Volume
0.05M
| -0.5 |
| 31 Dec 2023 | FY | 0.0% | 0.0% | -243.4% | -62.7% | 1.39 | 1.55 | -1.0 |
| 31 Dec 2022 | FY | -120.3% | -5519.3% | 558.5% | -96.6% | -4.14 | 0.84 | -1.4 |
| 31 Dec 2021 | FY | -2084.8% | -37633.0% | -117.1% | -46.7% | 0.93 | 4.22 | -2.3 |
| 31 Dec 2020 | FY | 5.7% | -916.3% | -472.7% | -88.9% | 2.81 | 3.20 | -2.0 |
| 31 Dec 2019 | FY | -10.9% | -290.9% | -642.1% | -120.3% | 0.09 | 1.19 | -3.0 |
| 31 Dec 2018 | FY | 12.3% | -169.8% | -141.7% | -84.8% | 0.00 | 2.46 | -1.3 |
| 31 Dec 2017 | FY | 20.7% | -131.6% | -113.1% | -74.8% | 0.00 | 2.92 | -1.9 |
| 31 Dec 2016 | FY | 19.3% | -31.1% | -43.9% | -31.6% | 0.00 | 3.52 | -2.4 |
| -1.2 |
| 30 Sept 2025 | Q3 | 0.0% | 0.0% | -33.3% | -22.4% | 0.05 | 3.18 | -0.5 |
| 30 Jun 2025 | Q2 | 0.0% | 0.0% | -147.7% | -46.9% | 0.22 | 1.47 | -0.4 |
| 31 Mar 2025 | Q1 | 0.0% | 0.0% | -89.6% | -41.8% | 0.02 | 1.85 | -0.5 |
| 31 Dec 2024 | Q4 | 0.0% | 0.0% | -72.5% | -33.3% | 0.36 | 1.82 | -0.6 |
| 30 Sept 2024 | Q3 | 0.0% | 0.0% | -29.0% | -16.4% | 0.37 | 2.28 | -1.3 |
| 30 Jun 2024 | Q2 | 0.0% | 0.0% | -47.5% | -16.7% | 0.84 | 1.52 | -0.5 |
| 31 Mar 2024 | Q1 | 0.0% | -1636.6% | -249.3% | -23.8% | 4.17 | 1.08 | -0.8 |
| 31 Dec 2023 | Q4 | 0.0% | 0.0% | -72.1% | -18.6% | 1.39 | 1.55 | -1.1 |